Vilya

Seattle, United States

Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease.

$21.0M raised

Jun 2024

Series A

Top Investors

Menlo VenturesMadronaARCH Venture PartnersLifeforce CapitalNVentures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Vilya raised?

Vilya has raised $21.0M in total funding. The most recent round was Series A. The last funding was announced in June 2024.

Who are Vilya's investors?

Vilya's investors include Menlo Ventures, Madrona, ARCH Venture Partners, Lifeforce Capital, NVentures.

Where is Vilya headquartered?

Vilya is headquartered in Seattle, United States.

What does Vilya do?

Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease.

What stage is Vilya at?

Vilya is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 4, 2024.

MLA

"Vilya — Funding & Investors." VCBacked, June 4, 2024, https://www.vcbacked.co/company/vilya. Accessed June 4, 2026.

APA

VCBacked. (2024). Vilya — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/vilya

Wikipedia (cite web)

{{cite web |title=Vilya — Funding & Investors |url=https://www.vcbacked.co/company/vilya |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 4, 2024.